Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2

Journal of Virology

Volumn 81, Issue 3, 2007, Pages 1451-1460

  Lundberg, Patric ^a   Welander, Paula V ^a,d   Edwards III, Carl K ^b,e   Van Rooijen, Nico ^c   Cantin, Edouard ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b AMGEN INC   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; IMMUNOREGULATION; INFECTION SENSITIVITY; INNATE IMMUNITY; MACROPHAGE; MORTALITY; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; ENCEPHALITIS, HERPES SIMPLEX; MICE; MICE, INBRED C57BL; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SIMPLEXVIRUS; TUMOR NECROSIS FACTOR-ALPHA;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; MUS; SIMPLEXVIRUS;

EID: 33846476600     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02243-06     Document Type: Article

References (73)

1. Aderka, D., P. Sorkine, S. Abu-Abid, D. Lev, A. Setton, A. P. Cope, D. Wallach, and J. Klausner. 1998. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. J. Clin. Investig. 101:650-659.
2. Adler, H., J. L. Beland, N. C. Del-Pan, L. Kobzik, J. P. Brewer, T. R. Martin, and I. J. Rimm. 1997. Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J. Exp. Med. 185:1533-1540.
3. Adler, H., J. L. Beland, N. C. Del-Pan, L. Kobzik, R. A. Sobel, and I. J. Rimm. 1999. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J. Neuroimmunol. 93:208-213.
4. Aggarwal, B. B., and K. Natarajan. 1996. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:93-124.
5. Amarzguioui, M., P. Lundberg, E. Cantin, J. Hagstrom, M. A. Behlke, and J. J. Rossi. 2006. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Nat. Protoc. 1:508-517.
6. Benedict, C. A., and C. F. Ware. 2001. Virus targeting of the tumor necrosis factor superfamily. Virology 289:1-5.
7. Bjornberg, F., M. Lantz, I. Olsson, and U. Gullberg. 1994. Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms. Lymphokine Cytokine Res. 13:203-211.
8. Bossen, C., K. Ingold, A. Tardivel, J. L. Bodmer, O. Gaide, S. Hertig, C. Ambrose, J. Tschopp, and P. Schneider. 2006. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J. Biol. Chem. 281:13964-13971.
9. Cantin, E., B. Tanamachi, and H. Openshaw. 1999. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 73:3418-3423.
10. Cantin, E., B. Tanamachi, H. Openshaw, J. Mann, and K. Clarke. 1999. Gamma interferon (IFN-γ) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-γ ligand null-mutant mice. J. Virol. 73:5196-5200.
11. Cantin, E. M., D. R. Hinton, J. Chen, and H. Openshaw. 1995. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:4898-4905.
12. Carr, D. J. J., and S. Noisakran. 2002. The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4+, α/β T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon. J. Virol. 76:9398-9406.
13. Chen, S. H., J. E. Oakes, and R. N. Lausch. 1994. Synergistic anti-herpes effect of TNF-alpha and IFN-gamma in human corneal epithelial cells compared with that in corneal fibroblasts. Antivir. Res. 25:201-213.
14. Cheung, T. C., I. R. Humphreys, K. G. Potter, P. S. Norris, H. M. Shumway, B. R. Tran, G. Patterson, R. Jean-Jacques, M. Yoon, P. G. Spear, K. M. Murphy, N. S. Lurain, C. A. Benedict, and C. F. Ware. 2005. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpes-virus entry mediator cosignaling pathway. Proc. Natl. Acad. Sci. USA 102:13218-13223.
15. Cook, M. C., H. Korner, D. S. Riminton, F. A. Lemckert, J. Hasbold, M. Amesbury, P. D. Hodgkin, J. G. Cyster, J. D. Sedgwick, and A. Basten. 1998. Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J. Exp. Med. 188:1503-1510.
16. Corey, L., and P. G. Spear. 1986. Infections with herpes simplex viruses (1). N. Engl. J. Med. 314:686-691.
17. Croft, M. 2005. The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA. Trends Immunol. 26:292-294.
18. Crowe, P. D., T. L. VanArsdale, R. G. Goodwin, and C. F. Ware. 1993. Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation. J. Immunol. 151:6882-6890.
19. Cullen, B. R. 2006. Enhancing and confirming the specificity of RNAi experiments. Nat. Methods 3:677-681.
20. Daheshia, M., S. Kanangat, and B. T. Rouse. 1998. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp. Eye Res. 67:619-624.
21. Decman, V., M. L. Freeman, P. R. Kinchington, and R. L. Hendricks. 2005. Immune control of HSV-1 latency. Viral Immunol. 18:466-473.
22. Edwards, C. K., III. 1999. PEGylated recombinant human soluble tumour necrosis factor receptor type 1 (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases. Ann. Rheum. Dis. 58(Suppl. 1):173-181.
23. Eissner, G., S. Kirchner, H. Lindner, W. Kolch, P. Janosch, M. Grell, P. Scheurich, R. Andreesen, and E. Holler. 2000. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J. Immunol. 164:6193-6198.
24. Feduchi, E., M. A. Alonso, and L. Carrasco. 1989. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1354-1359.
25. Ghiasi, H., S. L. Wechsler, R. Kaiwar, A. B. Nesburn, and F. M. Hofman. 1995. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J. Virol. 69:334-340.
26. Green, M. R., R. Treisman, and T. Maniatis. 1983. Transcriptional activation of cloned human beta-globin genes by viral immediate-early gene products. Cell 35:137-148.
27. Halford, W. P., B. M. Gebhardt. and D. J. Carr. 1996. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157:3542-3549.
28. He, J., H. Ichimura, T. Iida, M. Minami, K. Kobayashi, M. Kita, C. Sotozono, Y. I. Tagawa, Y. Iwakura, and J. Imanishi. 1999. Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL/6 mice after corneal HSV-1 infection. J. Interferon Cytokine Res. 19:609-615.
29. Heise, M. T., and H. W. Virgin IV. 1995. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:904-909.
30. Hendricks, R. L. 1999. Immunopathogenesis of viral ocular infections. Chem. Immunol. 73:120-136.
31. Herbein, G., and W. A. O'Brien. 2000. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc. Soc. Exp. Biol. Med. 223:241-257.
32. Holterman, A. X., K. Rogers, K. Edelmann, D. M. Koelle, L. Corey, and C. B. Wilson. 1999. An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection. J. Virol. 73:2058-2063.
33. Keadle, T. L., N. Usui, K. A. Laycock, J. K. Miller, J. S. Pepose, and P. M. Stuart. 2000. IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. Investig. Ophthalmol. Vis. Sci. 41:96-102.
34. Kirchner, S., S. Boldt, W. Kolch, S. Haffner, S. Kazak, P. Janosch, E. Holler, R. Andreesen, and G. Eissner. 2004. LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathway. J. Leukoc. Biol. 75:324-331.
35. Kodukula, P., T. Liu, N. V. Rooijen, M. J. Jager, and R. L. Hendricks. 1999. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol. 162:2895-2905.
36. Korner, H., M. Cook, D. S. Riminton, F. A. Lemckert, R. M. Hoek, B. Ledermann, F. Kontgen, B. Fazekas de St. Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27:2600-2609.
37. Krajcsi, P., and W. S. Wold. 1998. Inhibition of tumor necrosis factor and interferon triggered responses by DNA viruses. Semin. Cell Dev. Biol. 9:351-358.
38. Krummenacher, C., A. V. Nicola, J. C. Whitbeck, H. Lou, W. Hou, J. D. Lambris, R. J. Geraghty, P. G. Spear, G. H. Cohen, and R. J. Eisenberg. 1998. Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. J. Virol. 72:7064-7074.
39. Kumaraguru, U., I. A. Davis, S. Deshpande, S. S. Tevethia, and B. T. Rouse. 2001. Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. J. Immunol. 166:1066-1074.
40. Lantz, M., F. Bjornberg, I. Olsson, and J. Richter. 1994. Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms. J. Immunol. 152:1362-1369.
41. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:264-271.
42. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487-501.
43. Lundberg, P., P. Welander, H. Openshaw, C. Nalbandian, C. Edwards, L. Moldawer, and E. Cantin. 2003. A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice. J. Virol. 77:11661-11673.
44. MacLean, A., X. Q. Wei, F. P. Huang, U. A. Al-Alem, W. L. Chan, and F. Y. Liew. 1998. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J. Gen. Virol. 79:825-830.
45. Mauri, D. N., R. Ebner, R. I. Montgomery, K. D. Kochel, T. C. Cheung, G. L. Yu, S. Ruben, M. Murphy, R. J. Eisenberg, G. H. Cohen, P. G. Spear, and C. F. Ware. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8:21-30.
46. McDermott, M. F. 2001. TNF and TNFR biology in health and disease. Cell. Mol. Biol. (Noisy-le-Grand) 47:619-635.
47. Minagawa, H., K. Hashimoto, and Y. Yanagi. 2004. Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. J. Gen. Virol. 85:343-347.
48. Minami, M., M. Kita, X. Q. Yan, T. Yamamoto, T. Iida, K. Sekikawa, Y. Iwakura, and J. Imanishi. 2002. Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection. J. Interferon Cytokine Res. 22:671-676.
49. Mitoma, H., T. Horiuchi, N. Hatta, H. Tsukamoto, S. Harashima, Y. Kikuchi, J. Otsuka, S. Okamura, S. Fujita, and M. Harada. 2005. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 128:376-392.
50. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
51. Paludan, S. R., L. Malmgaard, S. Ellermann-Eriksen, L. Bosca, and S. C. Mogensen. 2001. Interferon (IFN)-gamma and herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1. Eur. Cytokine Netw. 12:297-308.
52. Perry, S. W., S. Dewhurst, M. J. Bellizzi, and H. A. Gelbard. 2002. Tumor necrosis factor-alpha in normal and diseased brain: conflicting effects via intraneuronal receptor crosstalk? J. Neurovirol. 8:611-624.
53. Peschon, J. J., D. S. Torrance, K. L Stocking, M. B. Glaccum, C. Often, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943-952.
54. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
55. Rossol-Voth, R., S. Rossol, K. H. Schutt, S. Corridori, W. de Cian, and D. Falke. 1991. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72:143-147.
56. Ruby, J., H. Bluethmann, and J. J. Peschon. 1997. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J. Exp. Med. 186:1591-1596.
57. Sainz, B., Jr., and W. P. Halford. 2002. Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76:11541-11550.
58. Sedgwick, J. D., D. S. Riminton, J. G. Cyster, and H. Korner. 2000. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol. Today 21:110-113.
59. Shimeld, C., J. L. Whiteland, S. M. Nicholls, E. Grinfeld, D. L. Easty, H. Gao, and T. J. Hill. 1995. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61:7-16.
60. Shimeld, C., J. L. Whiteland, N. A. Williams, D. L. Easty, and T. J. Hill. 1997. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J. Gen. Virol. 78:3317-3325.
61. Street, M., P. S. Coulson, C. Sadler, L. J. Warnock, D. McLaughlin, H. Bluethmann, and R. A. Wilson. 1999. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. J. Immunol. 163:4489-4494.
62. Stuehr, D. J., S. S. Gross, I. Sakuma, R. Levi, and C. F. Nathan. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169:1011-1020.
63. Stumpf, T. H., R. Case, C. Shimeld, D. L. Easty, and T. J. Hill. 2002. Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids. J. Gen. Virol. 83:1579-1590.
64. Tamada, K., K. Shimozaki, A. I. Chapoval, Y. Zhai, J. Su, S. F. Chen, S. L. Hsieh, S. Nagata, J. Ni, and L. Chen. 2000. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164:4105-4110.
65. Thomas, J., S. Gangappa, S. Kanangat, and B. T. Rouse. 1997. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 158:1383-1391.
66. Tumpey, T. M., S. H. Chen, J. E. Oakes, and R. N. Lausch. 1996. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:898-904.
67. Tumpey, T. M., H. Cheng, X. T. Yan, J. E. Oakes, and R. N. Lausch. 1998. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J. Leukoc. Biol. 63:486-492.
68. van Rooijen, N., J. Bakker, and A. Sanders. 1997. Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol. 15:178-185.
69. van Rooijen, N., A. Sanders, and T. K. van den Berg. 1996. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J. Immunol. Methods 193:93-99.
70. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
71. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331-367.
72. Wilhelm, P., U. Ritter, S. Labbow, N. Donhanser, M. Rollinghoff, C. Bogdan, and H. Korner. 2001. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 166:4012-4019.
73. Wong, G. H., L. A. Tartaglia, M. S. Lee, and D. V. Goeddel. 1992. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor [corrected]. J. Immunol. 149:3350-3353.